Cargando…

Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis

Coronavirus disease 2019 (COVID-19) has become a global pandemic. Previous studies showed that comorbidities in patients with COVID-19 are risk factors for adverse outcomes. This study aimed to clarify the association between nervous system diseases and severity or mortality in patients with COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ya, Chen, Yamin, Liu, Ming, Niu, Mingming, Song, Ziwei, Yan, Meili, Tian, Jinhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985867/
https://www.ncbi.nlm.nih.gov/pubmed/33583450
http://dx.doi.org/10.1017/S0950268821000376
_version_ 1783668332614909952
author Gao, Ya
Chen, Yamin
Liu, Ming
Niu, Mingming
Song, Ziwei
Yan, Meili
Tian, Jinhui
author_facet Gao, Ya
Chen, Yamin
Liu, Ming
Niu, Mingming
Song, Ziwei
Yan, Meili
Tian, Jinhui
author_sort Gao, Ya
collection PubMed
description Coronavirus disease 2019 (COVID-19) has become a global pandemic. Previous studies showed that comorbidities in patients with COVID-19 are risk factors for adverse outcomes. This study aimed to clarify the association between nervous system diseases and severity or mortality in patients with COVID-19. We performed a systematic literature search of four electronic databases and included studies reporting the prevalence of nervous system diseases in COVID-19 patients with severe and non-severe disease or among survivors and non-survivors. The included studies were pooled into a meta-analysis to calculate the odds ratio (OR) with 95% confidence intervals (95%CI). We included 69 studies involving 17 879 patients. The nervous system diseases were associated with COVID-19 severity (OR = 3.19, 95%CI: 2.37 to 4.30, P < 0.001) and mortality (OR = 3.75, 95%CI: 2.68 to 5.25, P < 0.001). Specifically, compared with the patients without cerebrovascular disease, patients with cerebrovascular disease infected with COVID-19 had a higher risk of severity (OR = 3.10, 95%CI: 2.21 to 4.36, P < 0.001) and mortality (OR = 3.45, 95% CI: 2.46 to 4.84, P < 0.001). Stroke was associated with severe COVID-19 disease (OR = 1.95, 95%CI: 1.11 to 3.42, P = 0.020). No significant differences were found for the prevalence of epilepsy (OR = 1.00, 95%CI: 0.42 to 2.35, P = 0.994) and dementia (OR = 2.39, 95%CI: 0.55 to 10.48, P = 0.247) between non-severe and severe COVID-19 patients. There was no significant association between stroke (OR = 1.79, 95%CI: 0.76 to 4.23, P = 0.185), epilepsy (OR = 2.08, 95%CI: 0.08 to 50.91, P = 0.654) and COVID-19 mortality. In conclusion, nervous system diseases and cerebrovascular disease were associated with severity and mortality of patients with COVID-19. There might be confounding factors that influence the relationship between nervous system diseases and COVID-19 severity as well as mortality.
format Online
Article
Text
id pubmed-7985867
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-79858672021-03-25 Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis Gao, Ya Chen, Yamin Liu, Ming Niu, Mingming Song, Ziwei Yan, Meili Tian, Jinhui Epidemiol Infect Review Coronavirus disease 2019 (COVID-19) has become a global pandemic. Previous studies showed that comorbidities in patients with COVID-19 are risk factors for adverse outcomes. This study aimed to clarify the association between nervous system diseases and severity or mortality in patients with COVID-19. We performed a systematic literature search of four electronic databases and included studies reporting the prevalence of nervous system diseases in COVID-19 patients with severe and non-severe disease or among survivors and non-survivors. The included studies were pooled into a meta-analysis to calculate the odds ratio (OR) with 95% confidence intervals (95%CI). We included 69 studies involving 17 879 patients. The nervous system diseases were associated with COVID-19 severity (OR = 3.19, 95%CI: 2.37 to 4.30, P < 0.001) and mortality (OR = 3.75, 95%CI: 2.68 to 5.25, P < 0.001). Specifically, compared with the patients without cerebrovascular disease, patients with cerebrovascular disease infected with COVID-19 had a higher risk of severity (OR = 3.10, 95%CI: 2.21 to 4.36, P < 0.001) and mortality (OR = 3.45, 95% CI: 2.46 to 4.84, P < 0.001). Stroke was associated with severe COVID-19 disease (OR = 1.95, 95%CI: 1.11 to 3.42, P = 0.020). No significant differences were found for the prevalence of epilepsy (OR = 1.00, 95%CI: 0.42 to 2.35, P = 0.994) and dementia (OR = 2.39, 95%CI: 0.55 to 10.48, P = 0.247) between non-severe and severe COVID-19 patients. There was no significant association between stroke (OR = 1.79, 95%CI: 0.76 to 4.23, P = 0.185), epilepsy (OR = 2.08, 95%CI: 0.08 to 50.91, P = 0.654) and COVID-19 mortality. In conclusion, nervous system diseases and cerebrovascular disease were associated with severity and mortality of patients with COVID-19. There might be confounding factors that influence the relationship between nervous system diseases and COVID-19 severity as well as mortality. Cambridge University Press 2021-02-15 /pmc/articles/PMC7985867/ /pubmed/33583450 http://dx.doi.org/10.1017/S0950268821000376 Text en © The Author(s) 2021 http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Gao, Ya
Chen, Yamin
Liu, Ming
Niu, Mingming
Song, Ziwei
Yan, Meili
Tian, Jinhui
Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis
title Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis
title_full Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis
title_fullStr Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis
title_full_unstemmed Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis
title_short Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis
title_sort nervous system diseases are associated with the severity and mortality of patients with covid-19: a systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985867/
https://www.ncbi.nlm.nih.gov/pubmed/33583450
http://dx.doi.org/10.1017/S0950268821000376
work_keys_str_mv AT gaoya nervoussystemdiseasesareassociatedwiththeseverityandmortalityofpatientswithcovid19asystematicreviewandmetaanalysis
AT chenyamin nervoussystemdiseasesareassociatedwiththeseverityandmortalityofpatientswithcovid19asystematicreviewandmetaanalysis
AT liuming nervoussystemdiseasesareassociatedwiththeseverityandmortalityofpatientswithcovid19asystematicreviewandmetaanalysis
AT niumingming nervoussystemdiseasesareassociatedwiththeseverityandmortalityofpatientswithcovid19asystematicreviewandmetaanalysis
AT songziwei nervoussystemdiseasesareassociatedwiththeseverityandmortalityofpatientswithcovid19asystematicreviewandmetaanalysis
AT yanmeili nervoussystemdiseasesareassociatedwiththeseverityandmortalityofpatientswithcovid19asystematicreviewandmetaanalysis
AT tianjinhui nervoussystemdiseasesareassociatedwiththeseverityandmortalityofpatientswithcovid19asystematicreviewandmetaanalysis